Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,184 | -50,171 | -31,523 | -31,045 | -27,082 |
| Depreciation Amortization | -603 | -64 | 32 | 467 | 642 |
| Income taxes - deferred | -2,254 | N/A | -9,376 | N/A | N/A |
| Accounts payable and accrued liabilities | 517 | 364 | -33 | 108 | 719 |
| Other Working Capital | 3,435 | 111 | 38,927 | 1,320 | -32 |
| Other Operating Activity | 27,656 | 7,819 | 5,066 | 3,463 | 1,483 |
| Operating Cash Flow | $-43,432 | $-41,942 | $3,093 | $-25,688 | $-24,269 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,085 | 69,490 | -107,136 | 17,818 | -18,285 |
| PPE Investments | N/A | N/A | -52 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -45 |
| Investing Cash Flow | $14,085 | $69,490 | $-107,188 | $17,818 | $-18,330 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 10,000 |
| Debt Repayment | N/A | -4,001 | -4,939 | -1,571 | N/A |
| Common Stock Issued | 525 | 656 | 55,050 | 81,969 | 31,000 |
| Other Financing Activity | 0 | 0 | -2,944 | -3,832 | -2,663 |
| Financing Cash Flow | $525 | $-3,345 | $47,167 | $76,566 | $38,337 |
| Beginning Cash Position | 50,335 | 26,132 | 83,061 | 14,284 | 18,546 |
| End Cash Position | 21,513 | 50,335 | 26,132 | 82,981 | 14,284 |
| Net Cash Flow | $-28,822 | $24,203 | $-56,929 | $68,697 | $-4,262 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,432 | -41,942 | 3,093 | -25,688 | -24,269 |
| Capital Expenditure | N/A | N/A | -52 | N/A | N/A |
| Free Cash Flow | -43,432 | -41,942 | 3,041 | -25,688 | -24,269 |